Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

FATE holding history

Fate Therapeutics Inc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overview All 13F holders of FATE Full Q2 2026 holdings

Shares (Q1 2022): 0; Sold out in Q1 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2021

Holdings of FATE by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2022	0	$0	0.0%	−3,821−100.0%	Sold out	Holders
Q4 2021	3,821	$224.0K	<0.1%	+15+0.4%	Added	Holders
Q3 2021	3,806	$226.0K	<0.1%	−584−13.3%	Reduced	Holders
Q2 2021	4,390	$381.0K	<0.1%	+4,390	New	Holders